Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiovascular Imaging Reports
Erschienen in: Current Cardiovascular Imaging Reports 3/2024

06.03.2024 | Review

Review of Ultrasound Enhancing Agents in Echocardiography for Better Diagnostic Accuracy

verfasst von: Ritu Thamman, Rajesh Janardhanan

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This abstract aims to examine the advancements in the utilization, indications, and implementation of ultrasound enhancing agents (UEAs) and their potential to enhance cost-effective diagnostics.

Recent Findings

The review highlights significant progress in the application of UEAs, particularly in improving the delineation of endocardial borders, enhancing interpretation of wall motion, and increasing diagnostic accuracy. Moreover, UEAs contribute to streamlining workflows and help avoid more expensive procedures, especially in cases with technically challenging or suboptimal studies.

Summary

UEAs have shown great promise in various medical scenarios, such as enhancing the visualization of the cardiac blood pool and enabling better assessment of ventricular borders, ventricular function, masses, and other intracavitary or myocardial abnormalities. This abstract presents an overview of the recent findings that underscore the potential benefits of UEAs in optimizing cardiac diagnostics while considering cost-effectiveness.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radio. 1968;3:356–66.CrossRef
2.
Porter TR, Abdelmoneim S, Belcik JT, McCulloch ML, Mulvagh SL, Olson JJ, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2014;27:797–810.PubMedCrossRef
3.
4.
Zullino S, et al. From micro- to nano-multifunctional theranostic platform: effective ultrasound imaging is not just a matter of scale. Mol Imaging. 2018;17:1536012118778216.PubMedPubMedCentralCrossRef
5.
6.
Omata D, et al. Lipid-based microbubbles and ultrasound for therapeutic application. Adv Drug Deliver Rev. 2020;154–155:236–44.CrossRef
7.
Chitnis PV, Koppolu S, Mamou J, et al. Influence of shell properties on high-frequency ultrasound imaging and drug delivery using polymer-shelled microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2013; 60.
8.
Chitnis PV, Lee P, Mamou J, et al. Rupture threshold characterization of polymer-shelled ultrasound contrast agents subjected to static overpressure. J Appl Phys. 2011;109:84906–8490610.PubMedCrossRef
9.
10.
Feinstein SB, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am College Cardiologyvol. 1990;16(2):316–24.CrossRef
11.
Mulvagh SL, et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr. 2008;21(11):1179–201 quiz 1281.PubMedCrossRef
12.
• Porter TR, Mulvagh SL, Abdelmoneim SS, Becher H, Belcik JT, Bierig M, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31:241–74.This paper updates the 2008 guidelines and replaces the term microbubbles with ultrasound enhancing agents. The paper also updates the new clinical evidence showing that UEAs are safe and efficacious for LV opacification in various clinical scenarios.PubMedCrossRef
13.
• Fraiche A, Strom J. Impact of ultrasound enhancing agents on clinical management. Curr Opin Cardiol. 2022;37(5):389–93.This paper updates the evidence that UEAs are cost effective in reducing downstream costs by improving endocardial border delineation. Improving workflows through enhanced reader confidence and study accuracy makes UEAs an asset in the echo lab despite its current laggard use.PubMedPubMedCentralCrossRef
14.
• Ellenberger, Katherine et al. “The effect of obesity on echocardiographic image quality.” Heart Lung Circ 2022; 31(2): 207–215.This paper demonstrates that increasing BMI, a surrogate for obesity, necessitates increasing UEA use to reduce nondiagnostic studies.
15.
16.
Wang M, et al. Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters. Sci Rep. 2018;8(1):3885.ADSPubMedPubMedCentralCrossRef
17.
Hu Y, et al. Membrane perforation and recovery dynamics in microbubble-mediated sonoporation. Ultrasound Med Biol. 2013;39(12):2393–405.PubMedCrossRef
18.
Man VH, et al. Molecular mechanism of the cell membrane pore formation induced by bubble stable cavitation. J Phys Chem B. 2019;123(1):71–8.PubMedCrossRef
19.
Yong Y, Wu D, Fernandes V, Kopelen HA, Shimoni S, Nagueh SF, Callahan JD, Bruns DE, Shaw LJ, Quinones MA, Zoghbi WA. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol. 2002;89(6):711–8.PubMedCrossRef
20.
21.
• Nagueh, Sherif F et al. “Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography.” J Am Soc Echocardiogr 2022; 35(6): 533–569. This paper provides the latest ASE guidelines on how to image in HCM patients and excellent examples of multimodality imaging incorporating UEAs.
22.
Urbano-Moral JA, et al. Contrast-enhanced echocardiographic measurement of left ventricular wall thickness in hypertrophic cardiomyopathy: comparison with standard echocardiography and cardiac magnetic resonance. J Am Soc Echocardiogr. 2020;33(9):1106–15.PubMedCrossRef
23.
Phelan D, et al. Comparison of ventricular septal measurements in hypertrophic cardiomyopathy patients who underwent surgical myectomy using multimodality imaging and implications for diagnosis and management. Am J Cardiol. 2017;119(10):1656–62.PubMedCrossRef
24.
Lang RM, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Euro Heart J Cardiovasc Imaging. 2015;16(3):233–70.CrossRef
25.
Aggarwal S, et al. Masking and unmasking of isolated noncompaction of the left ventricle with real-time contrast echocardiography. Circ Cardiovasc Imaging. 2017;10(11):e006999.PubMedCrossRef
26.
Gin KG, et al. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol. 1993;22(7):1994–2000.PubMedCrossRef
27.
Goyal SK, Punnam SR, Verma G, Ruberg FL. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound. 2008;10(6):50.CrossRef
28.
Bagur R, et al. A novel application of contrast echocardiography to exclude active coronary perforation bleeding in patients with pericardial effusion. Catheter Cardiovasc Interv: official journal of the Society for Cardiac Angiography & Interventions. 2013;82(2):221–9.CrossRef
29.
Weinsaft JW, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc imaging. 2016;9(5):505–15.PubMedCrossRef
30.
31.
Janardhanan R, et al. Usefulness of myocardial contrast echocardiography using low-power continuous imaging early after acute myocardial infarction to predict late functional left ventricular recovery. Am J Cardiol. 2003;92(5):493–7.PubMedCrossRef
32.
Kurt M, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am College Cardiol. 2009;53(9):802–10.CrossRef
33.
Senior R, et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Euro Heart J Cardiovasc Imaging. 2017;18(11):1205–1205af.CrossRef
34.
Plana JC, Mikati IA, Dokainish H, et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease: the OPTIMIZE trial. J Am Coll Cardiol Img. 2008;1:145.CrossRef
35.
Woodward W, et al. Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study. Euro Heart J Cardiovasc Imaging. 2022;23(5):689–98.CrossRef
36.
Becher H, von Bibra H. “Verstärkung von Doppler-Signalen bei Aorten- und Mitralvitien” [Enhancement of Doppler signals in aortic and mitral valve diseases]. Zeitschrift fur Kardiologie. 1997;86(12):1033–9.PubMedCrossRef
37.
Smith LA, et al. Contrast agent increases Doppler velocities and improves reproducibility of aortic valve area measurements in patients with aortic stenosis. J Am Soc Echocardiogr. 2004;17(3):247–52.PubMedCrossRef
38.
Dwivedi G, Hickman M, Senior R. Accurate assessment of aortic stenosis with intravenous contrast. Eur J Echocardiogr. 2006;7(2):165–7.PubMedCrossRef
39.
Byrd BF 3rd, et al. Contrast echocardiography enhances tricuspid but not mitral regurgitation. Clin Cardiol. 1991;14(11 Suppl 5):V10–4.PubMed
40.
Sorrell, Vincent, Kumar, Sachin. "Doppler contrast echocardiography". Establishing better standards of care in doppler echocardiography, computed tomography and nuclear cardiology, edited by Richard Fleming, IntechOpen 2011; https://​doi.​org/​10.​5772/​25152.
41.
Wei K, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97(5):473–83.PubMedCrossRef
42.
Abdelmoneim SS, et al. Microvascular function in Takotsubo cardiomyopathy with contrast echocardiography: prospective evaluation and review of literature. J Am Soc Echocardiogr. 2009;22(11):1249–55.PubMedCrossRef
43.
Lashin H, et al. Contrast-enhanced echocardiography application in patients supported by extracorporeal membrane oxygenation (ECMO): a narrative review. J Cardiothorac Vasc Anesth. 2022;36(7):2080–9.PubMedCrossRef
44.
Pereira JB, et al. The feasibility of contrast echocardiography in the assessment of right ventricular size and function. Echocardiography. 2019;36(11):1979–88.PubMedCrossRef
45.
46.
Johri AM, et al. ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J Am Soc Echocardiogr. 2020;33(6):670–3.PubMedPubMedCentralCrossRef
47.
Porter TR, Mulvagh SL, Abdelmoneim SS, Becher H, Belcik JT, Bierig M, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31:241–74.PubMedCrossRef
48.
Hoffmann R, et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Euro Heart J. 2005;26(6):607–16.CrossRef
49.
Lindner JR, Wei K. Contrast echocardiography. Curr Problems Cardiol. 2002;27(11):454–519.CrossRef
50.
• Cosyns B, Helfen A, Leong-Poi H, Senior R. How to perform an ultrasound contrast myocardial perfusion examination? Euro Heart J Cardiovasc Imaging. 2022;23(6):727–9.This paper shows how to give UEAs step by step and tips and tricks on how to enhance the images.CrossRef
51.
52.
D’Amico A, et al. Definity, an affinity for painful crisis: a case series describing vaso-occlusive pain crises in sickle cell patients undergoing echocardiogram with Definity contrast. Euro Heart J Case Rep. 2020;5(2):ytaa555.CrossRef
53.
Lindner JR, et al. Expert consensus statement from the American Society of Echocardiography on hypersensitivity reactions to ultrasound enhancing agents in patients with allergy to polyethylene glycol. J Am Soc Echocardiogr. 2021;34(7):707–8.PubMedPubMedCentralCrossRef
54.
Desai AK, et al. Hypersensitivity cross-reactivity for ultrasound-enhancing agents and COVID-19 vaccines. J Am Soc Echocardiogr. 2022;35(5):523–5.PubMedPubMedCentralCrossRef
55.
• Lindner JR. Contrast echocardiography: current status and future directions. Heart (British Cardiac Society). 2021;107(1):18–24.This paper reviews the latest clinical indications, current and emerging, for UEAs.PubMed
56.
Kopechek JA, McTiernan CF, Chen X, et al. Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function. Theranostics. 2019;9:7088–98.PubMedPubMedCentralCrossRef
57.
Pacella JJ, Brands J, Schnatz FG, Black JJ, Chen X, Villanueva FS. Treatment of microvascular micro-embolization using microbubbles and long-tone-burst ultrasound: an in vivo study. Ultrasound Med Biol. 2015;41:456–64.PubMedCrossRef
58.
Roos ST, Juffermans LJM, Slikkerveer J, Unger EC, Porter TR, Kamp O. Sonothrombolysis in acute stroke and myocardial infarction: a systematic review. IJC Heart Vess. 2014;4:1–6.CrossRef
59.
• Mathias W., Tsutsui J.M., Tavares B.G., et al."Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention". J Am Coll Cardiol 2019;73:2832–2842.This paper shows the first cardiology benefit of UEAs in myocardial infarction.
60.
Mason OR, Davidson BP, Sheeran P, et al. Augmentation of tissue perfusion in patients with peripheral artery disease using microbubble cavitation. J Am Coll Cardiol Img. 2020;13:641–51.CrossRef
Metadaten
Titel
Review of Ultrasound Enhancing Agents in Echocardiography for Better Diagnostic Accuracy
verfasst von
Ritu Thamman
Rajesh Janardhanan
Publikationsdatum
06.03.2024
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 3/2024
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-024-09589-5

Neu im Fachgebiet Kardiologie

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

13.05.2024 Chronische Herzinsuffizienz Nachrichten

Die Anlage eines interatrialen Shunts zur Reduktion des linksatrialen Drucks ist ein neuer Therapieansatz bei Herzinsuffizienz. Viele Patienten sprechen darauf an, andere jedoch nicht. 

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise